head and neck cancer
OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer
The French cancer center will use OncoDNA's blood-based next-generation sequencing test, OncoFollow, in its ongoing SCANDARE study.
Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay
The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow.
The company plans to publish new data on clinical sensitivity and specificity and has initiated multiple studies investigating new use cases.
OmniSeq, UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer
The Phase II trial will use OmniSeq's RNA-seq assay to determine whether patients should be treated with one of two agents combined with BMS' nivolumab.
Proteogenomic Analysis Uncovers HNSCC Subtypes, Possible Treatment Approaches
The researchers identified molecular subtypes of head and neck cancer that could be susceptible to CDK inhibitor, anti-EGFR antibody, or immunotherapy treatments.